Tandem Diabetes Care Inc
SWB:TD5A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tandem Diabetes Care Inc
SWB:TD5A
|
US |
|
Pharvaris NV
F:9EN
|
NL |
|
E
|
Equity Residential
F:EQR
|
US |
|
Edgio Inc
NASDAQ:EGIO
|
US |
|
Hinduja Global Solutions Ltd
NSE:HGS
|
IN |
|
Daiichi Sankyo Co Ltd
TSE:4568
|
JP |
|
Ypsomed Holding AG
OTC:YPHDF
|
CH |
Wall St Price Targets
TD5A Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for TD5A is 27.35 EUR with a low forecast of 14.53 EUR and a high forecast of 48.74 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TD5A's stock price target?
Price Target
27.35
EUR
According to Wall Street analysts, the average 1-year price target for TD5A is 27.35 EUR with a low forecast of 14.53 EUR and a high forecast of 48.74 EUR.
What is the Revenue forecast for Tandem Diabetes Care Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Tandem Diabetes Care Inc?
Projected CAGR
14%
The compound annual growth rate for Gross Profit over the next 5 years is 14%.
